Preparation method for core-shell structure drug carrier for real-time monitoring drug release through near-infrared light stimulation
A core-shell structure and real-time monitoring technology, which is applied to the photodissociation of drugs in the body, pharmaceutical formulations, medical preparations of non-active ingredients, etc., can solve the problems of inability to effectively monitor drug release, and achieve a wide range of applications , Avoid biological toxicity, high precision effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific Embodiment approach 1
[0030] Embodiment 1: The method for preparing a drug carrier with a core-shell structure that is excited by near-infrared light and monitors drug release in real time in this embodiment is specifically carried out according to the following steps:
[0031] 1. Synthesis of the upconversion nanoparticle core: mix yttrium chloride hexahydrate, ytterbium chloride hexahydrate and thulium chloride hexahydrate to obtain a mixture, then add oleic acid and octadecene to the mixture for reaction, and protect the mixture under argon Under the condition of stirring, the reaction temperature was raised from room temperature to 160 ° C, and stirred for 1 h under the protection of argon and the temperature was 160 ° C, and then the temperature was naturally cooled from 160 ° C to 50 ° C, then the mixed solution A was added, and Stir for 40min under the protection of argon and a temperature of 50°C, then raise the temperature from 50°C to 75°C, and keep it for 30min under the protection of arg...
specific Embodiment approach 2
[0042] Specific embodiment two: the difference between this embodiment and specific embodiment one is that the volume ratio of the mass of lutetium chloride hexahydrate described in step two to oleic acid is 1mg:0.067mL. Other steps and parameters are the same as those in the first embodiment.
specific Embodiment approach 3
[0043] Specific embodiment three: the difference between this embodiment and specific embodiment one or two is that the volume ratio of the mass of lutetium chloride hexahydrate described in step two to octadecene is 1mg:0.125mL. Other steps and parameters are the same as those in Embodiment 1 or 2.
PUM
Property | Measurement | Unit |
---|---|---|
concentration | aaaaa | aaaaa |
diameter | aaaaa | aaaaa |
pore size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com